In-depth information and trending research on multiple sclerosis, patient perspectives, and expert advice on how to manage MS symptoms.
The new medications, siponimod (Mayzent, Novartis) and cladribine (Mavenclad, EMD Serono), bring treatment options to active secondary progressive multiple sclerosis (SPMS). Most treatments approved for MS are for relapsing, rather than progressive, forms of the disease.
Multiple sclerosis is a chronic and progressive disease of the central nervous system. Nearly one million people in the United States are living with MS.
A number of disease-modifying therapies (DMTs) are effective in decreasing the frequency of relapses and the number of lesions in the brain or spinal cord.
Patients living with multiple sclerosis (MS) in the US may try these disease-modifying therapies (DMTs) to slow down the long-term progression of the disease.
Multiple sclerosis requires you to learn large amounts of information. During pregnancy, one concern is your MS medication.
Living with MS and RA, Lisa Emrich is a powerful patient advocate who inspires people to live better and stay active.
Award-winning author, chef and blogger, Trevis L. Gleason was diagnosed with secondary progressive multiple sclerosis in 2001.